#breast feeding

The Department of Health and Human Services has updated its HIV treatment and prevention guidelines for pregnant people and their infants.

Study results confirm that dolutegravir is a safe and effective treatment for pregnant women with HIV.

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.

The Well Project asked A Girl Like Me blogger Heather O’Connor about breastfeeding as a woman living with HIV in the United States.

Dozens of breast milk samples from women with the coronavirus suggest that breast milk isn’t a source of infection for infants.

How do current HIV and breastfeeding guidelines impact women’s lives? We convened a session with community experts at USCA 2019 to discuss.

Deciding how to feed your infant can be confusing for parents with HIV. Read about benefits & risks of several options for nourishing a baby

Our upcoming “Breastfeeding and HIV: What We Know and Considerations for Informed Choices” helps sort out fact from fiction.

Both cases involve mothers with an undetectable, or at least very low, viral load transmitting HIV to their babies.

The evidence remains inconclusive, with a few reports of women with a very low viral load transmitting HIV to their babies.

This is according to extended follow-up of a trial that gave HIV-positive breast-feeding mothers treatment or prophylaxis for their infant.

An unacceptably high rate of mother-to-child transmission of HIV still occurs in many African nations, often through breast feeding.

HIV-positive breast-feeding mothers can nearly eliminate the risk of transmitting HIV to their babies by taking ARVs.

A considerable proportion of those offered the HIV prevention method went on Truvada when offered it before, during or after pregnancy.